TORONTO, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, the premier provider of eClinical software solutions and services to small to mid-sized life sciences organizations, will be exhibiting at the 2017 ASH Annual Meeting in Atlanta, Georgia, December 9-11, 2017.
Axiom is positioned at Booth 3033 where attendees are invited to join Axiom team members for gourmet coffee along with their Fusion demonstration.
The ASH Annual Meeting and Exhibition is the world’s most comprehensive annual event in malignant and non-malignant hematology, celebrating the latest research and clinical advances in the field. The 59th ASH Annual Meeting will provide countless opportunities for participants to advance their research, improve their practice, and connect with colleagues.
“Our team is looking forward to learning about the needs of the attendees and sharing information about how our award-winning Fusion eClinical Suite enables them to manage their clinical trials more effectively and efficiently. Being ‘Truly Unified’ makes our product offering unique in the industry, and we are passionate about sharing what that distinction means and how it benefits our clients short and long term. By delivering a truly connected hub, Fusion empowers sponsors to successfully manage every aspect of their study from a single logon while lowering overall study management costs. Included in the connected hub are EDC, DM, IWRS, Inventory Management, Safety, and Payment Tracking, among other powerful components,” conveyed Andrew Schachter, CEO and Founder.
“Fusion eClinical Suite provides uniquely tailored reports to support clinical oncology studies, including tumour response assessment and tracking, patient profiles, and biomarker reports. Axiom’s client roster includes many sponsors working on global oncology and plasma cell disorders including studies for the treatment of Multiple Myeloma, AML, CML, Hodgkin Lymphoma and Leukemia, among others. The easy-to-use, modular suite of tools is extremely flexible, enabling sponsors to manage all study data from Phase I to complex Phase III trials without having to change platforms or source additional vendors. It works exceptionally well for all studies, supporting US to global studies and enabling them to operate with far greater efficiency - speeding time to market.” shared Dr. Robert Arbeit, Chief Clinical Scientist.
Heather Williams, Senior Director of Client Engagement added “We have recently launched an ‘Apples to Apples’ challenge where we invite interested parties to evaluate the differences of our offering in comparison to alternatives. Please come and see us for details!”.
About Axiom Real-Time Metrics
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: DM, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.
Contact
Axiom Real-Time Metrics
solutions@axiom.cc
+1.877.321.9191
PR Contact
Sarah Glofcheskie
sarahg@axiom.cc
+1.647.588.9073